Myelin is a dynamic, multilamellar membrane which ensheathes axons, providing the structural basis for saltatory nerve conduction which allows for increases in the speed of action potential propagation and dramatic savings in both energy consumption and space requirements; without myelin, neurons would have to have significantly larger diameters to achieve the same conduction speed [1] [2] [3] . The myelin sheath also participates in bidirectional communication with both its partner axons and the environment [1] [2] [3] . For example, myelin regulates axon diameter and is a key player in ion channel clustering at nodes of Ranvier [4] . Myelin-associated glycoprotein can inhibit neurite outgrowth during axonal regeneration; reciprocally, neurons regulate myelin gene expression, oligodendrocyte survival [1] and, as recently reported by Trajkovic et al. [5] , myelin proteolipid protein recruitment to the membrane. Loss or damage of myelin results in serious neurological disorders such as multiple sclerosis [1] . Remyelination is limited to a few lamellae, restoration of function is generally poor, and therapies remain suboptimal. The interdependence of myelin and axons takes on increasing importance with recognition of axonal degeneration in demyelinating disease.
Myelin biogenesis is a major part of brain development. As oligodendrocytes enter terminal differentiation, coordinated myelin gene expression is initiated, oligodendrocyte processes interact with axons, and myelin is produced as a specialization of the oligodendrocyte plasma membranes on a remarkable scale of approximately 5-50 x 10 3 mm 2 membrane per cell per day [2, 3] . Although myelin-like membranes are synthesized in culture without neuronal contact, in vivo the quantity and stability of myelin is strongly enhanced by oligodendrocyte-neuron interactions [2, 3] . While myelin has a relatively simple pattern of major proteins, there are myriad quantitatively, though certainly not functionally, 'minor' proteins [6] , some of which have been implicated in demyelinating diseases [7] . Further, myelin has multiple domains: myelin basic protein and proteolipid protein are found abundantly in compact internodal myelin; oligodendrocyte specific protein is localized to junctions that spiral through the myelin sheath; neurofascin-155 is concentrated at paranodes; and myelin-associated glycoprotein and myelin oligodendrocyte protein are concentrated in periaxonal and outer lamellae, respectively [2, 4] .
This asymmetric distribution of proteins provides myelin with the potential for functional diversity and compartmentalization of activity. However, with the long distances myelin membrane components may need to travel along oligodendrocyte processes to reach their target membranes, this also imposes additional burdens on the biosynthetic and trafficking mechanisms. One would therefore expect that molecules that regulate and coordinate the trafficking and recruitment of transport carriers to the plasma membrane and cytoskeletal dynamics would be essential for oligodendrocyte differentiation and myelin biogenesis. For example, mRNA molecules encoding myelin basic protein are transported to compact myelin in granules that contain specific components of the translation and transport machineries [2] . Exocytic transport regulators, such as Rab3a, the exocyst components Sec8 and Sec6, and the exocyst regulator RalA, are expressed at high levels in myelin; Rab3a and the v-SNARE synaptobrevin-2 are up-regulated during maturation of oligodendrocytes; and Sec8 is central for oligodendrocyte process growth and arborization [2, 8, 9] . A recent genetic screen in zebrafish [10] showed that N-ethylmaleimide sensitive factor, a protein critical for membrane fusion, is required for correct expression of myelin basic protein and formation of nodes of Ranvier.
Current hypotheses suggest that recycling endosomes play central roles in protein sorting and trafficking, both during plasma membrane recycling and as an intermediate step during cargo transport from the trans-Golgi network to the plasma membrane [11] (Figure 1) . Trajkovic et al. [5] investigated how axonal signals might control myelin biogenesis, obtaining results that suggest that late endosomes/lysosomes may contribute to this process. For this, they used first primary oligodendrocytes, and then, more extensively, two cell lines with some of the characteristics of oligodendrocytes. They concentrated on the major myelin protein proteolipid protein, the biosynthesis and transport of which coincide with the induction of myelination [12] . It is noteworthy that perturbations in the transport and or degradation pathways for protein proteolipid are associated with major myelin pathologies [1] .
Taking advantage of the fact that, in one of the cell lines (Olineu), proteolipid protein is normally detected at minimal levels on the plasma membrane, Trajkovic et al. [5] showed that the amount of proteolipid protein on the cell surface increased in the presence of neurons or neuron-conditioned medium. This could in principle be due to reduced proteolipid protein endocytosis and/or increased proteolipid protein trafficking to the cell surface. Using another cell line (OLN-93) that does express proteolipid protein on the surface, they showed that neuronal signals reduced the internalization of surface proteolipid protein in a clathrinindependent process that involved the actin cytoskeleton and RhoA, a small GTPase known to couple the actin cytoskeleton to membrane dynamics [13] . In both cell lines, as well as in primary oligodendrocytes, a portion of proteolipid protein was present in a LAMP1-positive late endosome/lysosome compartment. In primary oligodendrocytes, overall endocytosis was also reduced in the presence of neurons, whereas the half-life of proteolipid protein was not changed. Quantitative analysis is needed to clarify the effect neuronal signals have on endocytosis and exocytosis in oligodendrocytes and the amount of proteolipid protein present in the post-Golgi exocytic compared to the endosomal compartment in primary oligodendrocytes both in vivo and in vitro (for example, we find that only about 40-50% of proteolipid protein is co-localized with LAMP-1 in primary oligodendrocytes even in the absence of neurons).
To determine whether neuronal signaling also increases proteolipid protein transport to the membrane, Trajkovic et al. [5] analyzed the motility of a proteolipid protein-EGFP fluorescent fusion protein and late endosome/lysosome carriers labeled with the marker lysotracker in the Oli-neu cell line. In the absence of neurons, they found that particle motility was, perhaps surprisingly, minimal; in the presence of neurons, carrier motility was increased to approximately 29% of total particles, a level of activity similar to that normally observed in primary oligodendrocytes cultured without neurons (our unpublished data). In addition, in the presence of neurons, the fusion of lysotracker-positive carriers with the Oli-neu cell membrane was also elevated. This indicates that neuronal signal(s) increase the transport and recruitment of late endosome/lysosome carriers to the plasma membrane.
There are, however, some reasons for caution in this interpretation. The fact that proteolipid protein is present at reduced levels on the surface in Oli-neu cells compared to primary oligodendrocytes suggests that Oli-neu cells may lack part of the machinery involved in exocytic proteolipid protein transport, or that they recycle proteolipid protein much more rapidly than primary oligodendrocytes. Quantifications of anterograde and retrograde carrier movement and membrane fusion events in primary oligodendrocytes compared to Oli-neu/OLN-93 cells would be important in order to address this. Optimization of methods that allow combined genetic and time-lapse microscopy analyses of myelination, in particular primary oligodendrocytes co-cultured with neurons [14] , or in vivo studies in zebrafish [10] , should contribute to a better understanding of these phenomena.
An additional interesting finding in this study is that soluble neuronal signals are sufficient for stimulating proteolipid protein insertion into the membrane. Effects of pharmacological inhibitors suggest that cyclic AMP (cAMP) and protein kinase A (PKA) have a role in proteolipid protein trafficking, consistent with previous data showing that cAMP stimulation increases oligodendrocyte differentiation [15] . However, as cAMP alone stimulates proteolipid protein surface expression relatively modestly, compared to neuronconditioned medium, other molecules, as well as direct oligodendrocyte-neuron interactions, are likely to contribute to the polarized organization of the myelin membrane.
The new study of Trajkovic et al. [5] provides further evidence that myelin biogenesis responds to neuronal signals, and indicates that at least a portion of proteolipid protein trafficking could occur via endosomes. Incorporating these findings, we propose a general model in which neurons, via soluble signals ( Figure 1A-E) and/or surface adhesion molecules ( Figure 1F,G) , activate oligodendrocyte intracellular signaling pathways, such as cAMP/ PKA, leading to a decrease in membrane recycling ( Figure 1A) , and/or increase in the recruitment of transport carriers from either an endosomal ( Figure 1B) or an exocytic compartment ( Figure 1C ) [11, 16, 17] . This may involve modulation of carrier motility via molecular motor activation and cytoskeletal remodeling ( Figure 1D) ; vesicle docking, for example by favoring interactions between Rabs and Rab effectors ( Figure 1E) ; and/or SNAREmediated fusion. Additionally, extracellular signals transmitted via integrins ( Figure 1G ) may regulate cytoskeleton dynamics via RhoGTPases and Fyn [18, 19] , and the recruitment of trafficking carriers to the membrane via transport proteins such as Rab, RalA and the exocyst [9, 20] . Future studies are expected to confirm and characterize the molecular players involved in these processes.
